Navigation Links
Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly
Date:10/5/2009

(Boston) Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000. The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.

The number of cosmetic and non-cosmetic surgical procedures performed by dermatologic surgeons has been rising rapidly, but there are few consistent data sources that track procedure volumes over time. Accurate reporting is critical to assess adequacy of current training for residents and fellows to meet patient demand. In addition, reporting is critical for making future workforce projection models of the need for additional dermatologic surgeons and to anticipate the proportion of demand in cosmetic and non-cosmetic dermatologic surgery.

Using data from the 2001 to 2007 American Society for Dermatologic Surgery (ASDS) member survey, the researchers found that dermatologic surgeons performed an estimated 3.4 million cosmetic and non-cosmetic surgical procedures; in 2007, it was estimated that a total of 7.6 million procedures were performed (120 percent rate of growth between 2001 and 2007). The procedures with the greatest increase during this time period were soft tissue augmentation (405 percent increase), botulinum toxin injections (324 percent increase), and non-ablative skin rejuvenation (laser, light, and radiofrequency sources) (330 percent increase). More modest increases were noted in skin cancer procedures (85 percent increase) and ablative resurfacing procedures (66 percent increase).

According to the researchers, there are two important trends fueling the growth in the number of surgical procedures performed by dermatologic surgeons. "They include the overall advancements in procedural facets of dermatology as a specialty during the last decade combined with the increased societal emphasis on skin cancer prevention and early diagnosis, as well as a desire to prevent and reverse the skin signs of aging," said lead author Emily Tierney, MD, an assistant professor of dermatology at BUSM.

Tierney further explains, "Dermatologists have been integral to the rapid evolution of photomedicine, with the advances in laser and light devices to treat a diversity of skin conditions. These include actinic keratoses to nonmelanoma skin cancer, pigmentary and vascular disorders, hair and tattoo removal, wrinkles and other signs of photoaging. In addition, the popularity and growth in minimally invasive cosmetic procedures, including botulinum toxin injections, dermal fillers, and nonablative skin rejuvenation techniques (chemical peels and laser, light, and radiofrequency devices) have increased exponentially."

The researchers anticipate that the role for the dermatologist in a diversity of surgical pursuits, ranging from skin cancer treatment, minimally invasive cosmetic, and laser procedures to complex cosmetic and reconstructive procedures, will continue to grow and expand and contribute to the quality and diversity of procedures performed.


'/>"/>

Contact: Gina M. Digravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Using synthetic evolution to study the brain: Researchers model key part of neurons
2. Researchers at Boston University School of Medicine incorporate multisite geriatric clerkship
3. Researchers use computational models to study fear
4. Researchers develop an integrated treatment for veterans with chronic pain and posttraumatic stress
5. UT Houston, Jamaica researchers launch autism study
6. Paul Marks prize recognizes 3 young cancer researchers
7. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
8. Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery
9. U of T researchers create microchip that can detect type and severity of cancer
10. Researchers believe hormone therapy should not be stopped prior to mammograms
11. McMaster researchers discover a new antibacterial lead
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: